Detail akcie AVITA Therapetcs Rg online

Business Summary: AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, AVITA Medical Inc revenues increased 18% to $54M. Net loss decreased 26% to $37M. Revenues reflect United Kingdom segment increase from $159K to $345K. Lower net loss reflects RECELL System segment loss decrease of 80% to $9.2M. Basic Earnings per Share excluding Extraordinary Items increased from -$1.95 to -$1.37.